Free Trial
→ [RFK Jr CONFIRMED] Here’s why Dems are TERRIFIED (From NewMarket Health Publishing, LLC.) (Ad) Free OPRX Stock Alerts

OptimizeRx (OPRX) Short Interest Ratio & Short Volume

OptimizeRx logo
$5.78 -0.41 (-6.62%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$5.78 +0.00 (+0.09%)
As of 02/21/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

OptimizeRx Short Interest Data

OptimizeRx (OPRX) has a short interest of 1.28 million shares, representing 8.14% of the float (the number of shares available for trading by the public). This marks a 4.92% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.3, indicating that it would take 4.3 days of the average trading volume of 120,509 shares to cover all short positions.

Current Short Interest
1,280,000 shares
Previous Short Interest
1,220,000 shares
Change Vs. Previous Month
+4.92%
Dollar Volume Sold Short
$7.10 million
Short Interest Ratio
4.3 Days to Cover
Last Record Date
January 31, 2025
Outstanding Shares
18,420,000 shares
Float Size
15,730,000 shares
Short Percent of Float
8.14%
Today's Trading Volume
62,604 shares
Average Trading Volume
120,509 shares
Today's Volume Vs. Average
52%
Short Selling OptimizeRx?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for OptimizeRx and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

OPRX Short Interest Over Time

OPRX Days to Cover Over Time

OPRX Percentage of Float Shorted Over Time

OptimizeRx Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20251,280,000 shares $7.10 million +4.9%8.1%4.3 $5.55
1/15/20251,220,000 shares $6.03 million -1.6%7.8%4.1 $4.94
12/31/20241,240,000 shares $6.03 million +12.7%7.9%4.1 $4.86
12/15/20241,100,000 shares $5.49 million +10.0%6.9%4 $4.99
11/30/20241,000,000 shares $5.45 million -5.7%6.3%4.2 $5.45
11/15/20241,060,000 shares $4.05 million +10.8%6.6%5 $3.83
10/31/2024956,300 shares $4.99 million +4.8%6.0%7.4 $5.22
10/15/2024912,500 shares $5.93 million +8.7%5.8%7.2 $6.50
9/30/2024839,400 shares $6.48 million -2.9%5.3%6.9 $7.72
9/15/2024864,500 shares $6.74 million +0.1%5.4%7.2 $7.80
8/31/2024863,700 shares $7.18 million -8.2%5.4%7.4 $8.31
8/15/2024941,000 shares $7.90 million +1.0%5.9%7.9 $8.40
7/31/2024931,700 shares $10.16 million -7.8%5.9%7.1 $10.91
7/15/20241,010,000 shares $10.39 million No Change6.4%7.5 $10.29
6/30/20241,010,000 shares $10.10 million -1.0%6.4%7.4 $10.00
6/15/20241,020,000 shares $11.22 million -1.0%6.4%7.3 $11.00
5/31/20241,030,000 shares $12.42 million +12.5%6.4%6.7 $12.06
5/15/2024916,000 shares $12.06 million +12.7%5.7%6 $13.17
4/30/2024812,500 shares $8.29 million +29.7%5.1%6.1 $10.20
4/15/2024626,600 shares $6.47 million -4.5%3.9%5.2 $10.32
3/31/2024656,000 shares $7.97 million -13.1%4.1%5.5 $12.15
3/15/2024754,700 shares $9.58 million -3.3%4.7%6.4 $12.69
2/29/2024780,500 shares $12.36 million +0.3%4.9%5.6 $15.83
2/15/2024778,200 shares $12.38 million -0.1%4.9%5.5 $15.91
1/31/2024778,800 shares $11.00 million -19.6%4.9%4.8 $14.12
1/15/2024968,400 shares $14.31 million +1.3%6.1%5.4 $14.78
12/31/2023956,300 shares $13.68 million -0.1%6.0%5.1 $14.31
12/15/2023957,200 shares $10.56 million -1.0%6.0%5.2 $11.03
11/30/2023967,100 shares $9.20 million +5.0%N/A6.1 $9.51
11/15/2023921,300 shares $8.88 million +5.7%N/A5.2 $9.64
10/31/2023871,400 shares $7.02 million +10.7%N/A4.5 $8.06
10/15/2023787,000 shares $6.68 million +7.6%5.0%4.7 $8.49
9/30/2023731,300 shares $5.69 million +8.1%4.6%5 $7.78
9/15/2023676,600 shares $5.66 million +8.3%4.2%4.7 $8.37
8/31/2023624,800 shares $5.32 million -11.2%3.9%4.6 $8.52
8/15/2023703,200 shares $6.39 million -4.3%4.4%5.6 $9.08
7/31/2023734,600 shares $10.25 million +2.8%4.5%6.9 $13.95
7/15/2023714,700 shares $10.53 million -3.1%4.3%6.3 $14.74
6/30/2023737,900 shares $10.54 million -10.9%4.5%6.1 $14.29
6/15/2023827,700 shares $12.43 million +14.6%5.1%6.2 $15.02
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)

If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.

You MUST act before March 17th.
5/31/2023722,100 shares $10.14 million +1.6%4.4%3 $14.04
5/15/2023710,500 shares $9.29 million -19.7%4.3%2.8 $13.08
4/30/2023884,500 shares $13.29 million -3.7%5.4%3.6 $15.03
4/15/2023918,000 shares $13.23 million -14.2%5.6%3.7 $14.41
3/31/20231,070,000 shares $15.65 million -24.7%6.6%4.2 $14.63
3/15/20231,420,000 shares $18.37 million -4.7%8.7%5.6 $12.94
2/28/20231,490,000 shares $26.60 million -6.3%9.1%8.2 $17.85
2/15/20231,590,000 shares $29.03 million +3.3%9.7%11 $18.26
1/31/20231,540,000 shares $27.64 million +29.4%9.4%8.7 $17.95
1/15/20231,190,000 shares $22.04 million +3.5%7.3%6.5 $18.52
12/30/20221,150,000 shares $19.32 million +8.5%7.0%6.1 $16.80
12/15/20221,060,000 shares $18.56 million +3.9%6.5%5.4 $17.51
11/30/20221,020,000 shares $21.51 million -9.7%6.2%5.1 $21.09
11/15/20221,130,000 shares $24.91 million +2.7%6.9%5.4 $22.04
10/31/20221,100,000 shares $16.96 million +0.9%N/A4.2 $15.42
10/15/20221,090,000 shares $15.01 million +11.2%6.6%4.1 $13.77
9/30/2022980,000 shares $14.52 million -1.7%5.9%3.5 $14.82
9/15/2022996,800 shares $15.53 million +3.7%6.0%3.6 $15.58
8/31/2022961,500 shares $15.26 million -10.1%6.1%3.7 $15.87
8/15/20221,070,000 shares $16.69 million -12.3%6.7%4.3 $15.60
7/31/20221,220,000 shares $27.41 million -12.9%7.7%6.4 $22.47
7/15/20221,400,000 shares $41.10 million -4.1%8.8%7.1 $29.36
6/30/20221,460,000 shares $39.99 million +13.2%15.2%8.2 $27.39
6/15/20221,290,000 shares $34.31 million +5.7%13.4%7.2 $26.60
5/31/20221,220,000 shares $31.21 million +9.9%7.7%7 $25.58
5/15/20221,110,000 shares $27.88 million -3.5%7.0%6 $25.12
4/30/20221,150,000 shares $32.33 million -17.3%7.2%6.1 $28.11
4/15/20221,390,000 shares $54.13 million -5.4%8.9%7.7 $38.94
3/31/20221,470,000 shares $55.43 million -9.3%9.4%7.4 $37.71
3/15/20221,620,000 shares $59.44 million +14.9%10.4%7.3 $36.69
2/28/20221,410,000 shares $63.86 million +19.5%9.0%5.6 $45.29
2/15/20221,180,000 shares $57.38 million -1.7%7.6%4.5 $48.63
1/31/20221,200,000 shares $53.92 million +0.8%7.7%4.3 $44.93
1/15/20221,190,000 shares $59.12 million -7.0%7.7%4.3 $49.68
12/31/20211,280,000 shares $79.50 million +3.2%8.2%4.9 $62.11
12/15/20211,240,000 shares $68.91 million -15.1%8.0%3.3 $55.57
11/30/20211,460,000 shares $94.90 million -0.7%9.4%4 $65.00
11/15/20211,470,000 shares $117.73 million -13.0%9.5%4.2 $80.09
10/29/20211,690,000 shares $163.42 million -1.7%11.0%5.4 $96.70
10/15/20211,720,000 shares $145.55 million +35.4%11.2%5.4 $84.62
9/30/20211,270,000 shares $108.65 million +19.8%8.3%4.2 $85.55
9/15/20211,060,000 shares $71.00 million -2.8%6.9%6.3 $66.98
8/31/20211,090,000 shares $72.14 million +9.7%7.1%7.3 $66.18
8/13/2021994,100 shares $61.75 million +13.1%6.5%6.7 $62.12
7/30/2021879,000 shares $48.58 million -2.8%5.8%5.7 $55.27
7/15/2021904,400 shares $46.06 million -2.0%6.0%6.1 $50.93
6/30/2021923,200 shares $57.15 million +5.1%6.6%5.8 $61.90
6/15/2021878,500 shares $45.75 million -3.3%5.9%5 $52.08
5/28/2021908,600 shares $44.63 million -3.7%6.1%4.4 $49.12
5/14/2021943,800 shares $40.36 million -3.0%N/A3.9 $42.76
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)

If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.

You MUST act before March 17th.
4/30/2021972,800 shares $48.85 million -2.6%N/A3.3 $50.22
4/15/2021999,200 shares $50.16 million -1.1%N/A3.4 $50.20
3/31/20211,010,000 shares $46.84 million +13.9%N/A3.4 $46.38
3/15/2021887,100 shares $40.18 million +1.9%N/A3.1 $45.29
2/26/2021871,000 shares $48.78 million -6.4%N/A3.4 $56.01
2/12/2021930,300 shares $50.21 million -9.7%N/A4.3 $53.97
1/29/20211,030,000 shares $48.65 million +4.2%8.2%5.5 $47.23
1/15/2021988,900 shares $39.55 million +7.1%7.9%6.3 $39.99
12/31/2020923,400 shares $28.81 million -4.9%7.5%6.1 $31.20
12/15/2020971,000 shares $28.37 million -10.9%7.8%5.7 $29.22
11/30/20201,090,000 shares $27.41 million -7.6%8.8%6.3 $25.15
11/15/20201,180,000 shares $28.74 million -1.7%9.5%7 $24.36
10/30/20201,200,000 shares $24.20 million -3.2%9.7%7.3 $20.17
10/15/20201,240,000 shares $26.90 million +3.3%10.1%7.2 $21.69
9/30/20201,200,000 shares $25.02 million +3.5%9.8%7.4 $20.85
9/15/20201,160,000 shares $23.49 million -3.3%9.6%8.5 $20.25
8/31/20201,200,000 shares $24.19 million -4.0%9.9%8.7 $20.16
8/14/20201,250,000 shares $22 million +21.4%10.3%8.5 $17.60
7/31/20201,030,000 shares $14.57 million +1.0%8.5%7.4 $14.15
7/15/20201,020,000 shares $15.24 million -1.9%8.5%7.7 $14.94
6/30/20201,040,000 shares $13.43 million +22.2%8.7%7.8 $12.91
6/15/2020851,300 shares $10.93 million -4.1%7.1%6.6 $12.84
5/29/2020888,000 shares $10.24 million -0.4%7.4%7.3 $11.53
5/15/2020891,400 shares $8.47 million +1.4%7.4%7.7 $9.50
4/30/2020878,800 shares $8.18 million -1.3%7.3%8.4 $9.31
4/15/2020890,700 shares $8.16 million +2.1%7.4%8.9 $9.16
3/31/2020872,000 shares $8.29 million -4.9%7.3%9.2 $9.51
3/13/2020916,600 shares $7.75 million +11.4%7.8%7.5 $8.46
2/28/2020823,200 shares $5.84 million -4.1%7.0%9 $7.10

OPRX Short Interest - Frequently Asked Questions

What is OptimizeRx's current short interest?

Short interest is the volume of OptimizeRx shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 1,280,000 shares of OPRX short. 8.14% of OptimizeRx's shares are currently sold short. Learn More on OptimizeRx's current short interest.

What is a good short interest ratio for OptimizeRx?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OPRX shares currently have a short interest ratio of 4.0. Learn More on OptimizeRx's short interest ratio.

Which institutional investors are shorting OptimizeRx?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of OptimizeRx: Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for OptimizeRx?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.14% of OptimizeRx's floating shares are currently sold short.

Is OptimizeRx's short interest increasing or decreasing?

OptimizeRx saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 1,280,000 shares, an increase of 4.9% from the previous total of 1,220,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is OptimizeRx's float size?

OptimizeRx currently has issued a total of 18,420,000 shares. Some of OptimizeRx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. OptimizeRx currently has a public float of 15,730,000 shares.

How does OptimizeRx's short interest compare to its competitors?

8.14% of OptimizeRx's shares are currently sold short. Here is how the short interest of companies in the industry of "business services" compare to OptimizeRx: National Research Co. (1.91%), Ooma, Inc. (1.81%), MultiPlan Co. (6.32%), 8x8, Inc. (5.16%), Zhihu Inc. (1.97%), trivago (0.31%), TSS, Inc. (0.87%), CPI Card Group Inc. (1.24%), Nutex Health Inc. (0.89%), Resources Connection, Inc. (2.31%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

What does it mean to sell short OptimizeRx stock?

Short selling OPRX is an investing strategy that aims to generate trading profit from OptimizeRx as its price is falling. OPRX shares are trading down $0.41 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against OptimizeRx?

A short squeeze for OptimizeRx occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OPRX, which in turn drives the price of the stock up even further.

How often is OptimizeRx's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OPRX, twice per month. The most recent reporting period available is January, 31 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:OPRX) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Secret financial plot unfolding in Washington DC… [DEVELOPING]
What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...
Timothy Sykes | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Grab This Altcoin Before Trump's Crypto Announcement
Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...
Crypto 101 Media | Sponsored
[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIED
Robert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...
NewMarket Health Publishing, LLC. | Sponsored
Market down? Do this now.
During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...
Colonial Metals | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Elon Takes Aim at Social Security
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...
Altimetry | Sponsored
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...
Weiss Ratings | Sponsored